SYRESpyre Therapeutics, Inc.Mar 7, 2019Q4 2018
Read transcript →Spyre Therapeutics, Inc. (SYRE) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$81.33
+0.69%
Mkt Cap $4.88B
SYRESpyre Therapeutics, Inc.Mar 7, 2019SYRESpyre Therapeutics, Inc.Mar 23, 2017Q4 2016
Read transcript →